Analysis of 2'-hydroxyflavanone (2HF) in mouse whole blood by HPLC-MS/MS for the determination of pharmacokinetic parameters.

2′-hydroxiflavanone HPLC-MS/MS flavonoid oral treatment pharmacokinetics

Journal

Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988

Informations de publication

Date de publication:
2023
Historique:
received: 12 10 2022
accepted: 13 02 2023
entrez: 27 3 2023
pubmed: 28 3 2023
medline: 28 3 2023
Statut: epublish

Résumé

Given the lack of investments, structure, and difficulty of metabolite isolation, promising natural product studies do not progress to preclinical studies, such as pharmacokinetics. 2'-Hydroxyflavanone (2HF) is a flavonoid that has shown promising results in different types of cancer and leishmaniasis. For accurate quantification of 2HF in BALB/c mouse blood, a validated HPLC-MS/MS method was developed. Chromatographic analysis was performed using C

Identifiants

pubmed: 36970405
doi: 10.3389/fchem.2023.1016193
pii: 1016193
pmc: PMC10033538
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1016193

Informations de copyright

Copyright © 2023 Gervazoni, Gonçalves-Ozorio, Ferreira-Paes, Silva, Silveira, Pereira, Pinto, Cunha-Junior and Almeida-Amaral.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Drug Discov Today. 2016 Feb;21(2):204-7
pubmed: 25617672
Curr Protoc Pharmacol. 2019 Sep;86(1):e67
pubmed: 31539923
Oncotarget. 2018 Apr 6;9(26):18053-18068
pubmed: 29719590
Asian Pac J Trop Med. 2012 Jun;5(6):485-97
pubmed: 22575984
Chem Biol Interact. 2007 May 1;167(3):193-206
pubmed: 17376416
PLoS Negl Trop Dis. 2018 Dec 6;12(12):e0006930
pubmed: 30521527
MAbs. 2020 Jan-Dec;12(1):1795492
pubmed: 32744170
Nat Biotechnol. 2009 Jul;27(7):633-41
pubmed: 19561596
Carcinogenesis. 2011 Apr;32(4):568-75
pubmed: 21304051
Cancer Lett. 2018 Dec 1;438:144-153
pubmed: 30223070
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Oct 1;1154:122195
pubmed: 32943176
Toxicol Sci. 2015 Jun;145(2):244-51
pubmed: 25724921
Molecules. 2020 Sep 16;25(18):
pubmed: 32947773
Clin Chim Acta. 2018 Oct;485:298-304
pubmed: 30006284
PLoS One. 2012;7(1):e29647
pubmed: 22253753
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 15;1137:121881
pubmed: 31881511
Dtsch Med Wochenschr. 2012 Dec;137(51-52):2738-40
pubmed: 23233307
Curr Med Chem. 2012;19(14):2128-75
pubmed: 22414103
Biochem Pharmacol. 2015 Aug 1;96(3):151-8
pubmed: 25957660
Anal Chem. 2004 Feb 1;76(3):839-47
pubmed: 14750883
Molecules. 2020 Nov 11;25(22):
pubmed: 33187049
Cancer Lett. 2020 Feb 28;471:135-146
pubmed: 31811906
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:73-80
pubmed: 30445290
Mol Nutr Food Res. 2012 May;56(5):761-74
pubmed: 22648623
Cancers (Basel). 2019 Oct 14;11(10):
pubmed: 31615091
Molecules. 2021 Jul 27;26(15):
pubmed: 34361667
Sci Rep. 2017 Jun 2;7(1):2714
pubmed: 28578404
Front Chem. 2020 Nov 23;8:579891
pubmed: 33330368
J Proteomics. 2019 Feb 10;192:233-245
pubmed: 30248461
J Agric Food Chem. 2017 Mar 22;65(11):2406-2413
pubmed: 28251856
Curr Med Chem. 2012;19(14):2176-228
pubmed: 22414104
Drug Metab Dispos. 2014 Nov;42(11):1858-66
pubmed: 25185260
J Clin Lab Anal. 2021 Mar;35(3):e23658
pubmed: 33219583
Int J Mol Sci. 2018 May 25;19(6):
pubmed: 29799486
Mol Carcinog. 2018 Dec;57(12):1751-1762
pubmed: 30136444
Biomed Chromatogr. 2019 Feb;33(2):e4391
pubmed: 30238480
Biomed Pharmacother. 2020 Dec;132:110809
pubmed: 33049584
J Anal Methods Chem. 2018 Dec 18;2018:4789196
pubmed: 30662789
Drug Test Anal. 2017 Aug;9(8):1124-1136
pubmed: 27794181

Auteurs

Luiza F O Gervazoni (LFO)

Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Gabriella Gonçalves-Ozorio (G)

Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Taiana Ferreira-Paes (T)

Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Aline C A Silva (ACA)

Laboratório de Farmacocinética, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Gabriel P E Silveira (GPE)

Laboratório de Farmacocinética, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Heliana M Pereira (HM)

Laboratório de Farmacocinética, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Douglas P Pinto (DP)

Laboratório de Farmacocinética, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Edézio F Cunha-Junior (EF)

Laboratório de Imunoparasitologia, Unidade Integrada de Pesquisa em Produtos Bioativos e Biociên-cias, Universidade Federal do Rio de Janeiro, Campus UFRJ, Macaé, Brazil.

Elmo E Almeida-Amaral (EE)

Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Classifications MeSH